Clinical Trial Update: Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating docetaxel, cisplatin, and radiation therapy for locally advanced, unresectable esophageal cancer; study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Esophageal Cancer | Phase 2 | Status: COMPLETED